Epigenetic Signature Can Predict Inherited, Non-inherited Forms of Breast Cancer | GenomeWeb

NEW YORK (GenomeWeb) – Researchers from University College London reported in Genome Medicine this week that a DNA methylation signature they've uncovered could predict the risk of a woman developing breast cancer.

Although they developed the signature by examining the blood of women who are BRCA1 carriers, it appeared to also be able to predict risk of non-hereditary breast cancer.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.